ReeNT

Tokyo, Japan

ReeNT is a biotechnology company that develops ENT medical solutions and regenerative medicines for the healthcare industry.

$3.8M raised

May 2026

Corporate Round

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has ReeNT raised?

ReeNT has raised $3.8M in total funding. The most recent round was Corporate Round. The last funding was announced in May 2026.

Who are ReeNT's investors?

ReeNT's investors include Mitsubishi UFJ Capital, Nissay Capital, Alfresa Holdings.

Where is ReeNT headquartered?

ReeNT is headquartered in Tokyo, Japan.

What does ReeNT do?

ReeNT is a biotechnology company that develops ENT medical solutions and regenerative medicines for the healthcare industry.

What stage is ReeNT at?

ReeNT is at the Corporate Round stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 27, 2026.

MLA

"ReeNT — Funding & Investors." VCBacked, May 27, 2026, https://www.vcbacked.co/company/reent. Accessed July 2, 2026.

APA

VCBacked. (2026). ReeNT — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/reent

Wikipedia (cite web)

{{cite web |title=ReeNT — Funding & Investors |url=https://www.vcbacked.co/company/reent |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 27, 2026.